收费全文 | 43764篇 |
免费 | 3353篇 |
国内免费 | 850篇 |
耳鼻咽喉 | 145篇 |
儿科学 | 396篇 |
妇产科学 | 377篇 |
基础医学 | 1934篇 |
口腔科学 | 303篇 |
临床医学 | 5184篇 |
内科学 | 2715篇 |
皮肤病学 | 293篇 |
神经病学 | 609篇 |
特种医学 | 800篇 |
外科学 | 1831篇 |
综合类 | 11832篇 |
现状与发展 | 2篇 |
一般理论 | 41篇 |
预防医学 | 16242篇 |
眼科学 | 243篇 |
药学 | 2027篇 |
289篇 | |
中国医学 | 2175篇 |
肿瘤学 | 529篇 |
2024年 | 141篇 |
2023年 | 693篇 |
2022年 | 1306篇 |
2021年 | 1779篇 |
2020年 | 2108篇 |
2019年 | 1373篇 |
2018年 | 1268篇 |
2017年 | 1256篇 |
2016年 | 1253篇 |
2015年 | 1231篇 |
2014年 | 3208篇 |
2013年 | 3354篇 |
2012年 | 3102篇 |
2011年 | 3414篇 |
2010年 | 2844篇 |
2009年 | 2410篇 |
2008年 | 2726篇 |
2007年 | 2502篇 |
2006年 | 2170篇 |
2005年 | 1758篇 |
2004年 | 1409篇 |
2003年 | 1100篇 |
2002年 | 823篇 |
2001年 | 684篇 |
2000年 | 584篇 |
1999年 | 429篇 |
1998年 | 360篇 |
1997年 | 335篇 |
1996年 | 291篇 |
1995年 | 268篇 |
1994年 | 182篇 |
1993年 | 104篇 |
1992年 | 99篇 |
1991年 | 146篇 |
1990年 | 123篇 |
1989年 | 107篇 |
1988年 | 106篇 |
1987年 | 84篇 |
1986年 | 108篇 |
1985年 | 90篇 |
1984年 | 92篇 |
1983年 | 77篇 |
1982年 | 82篇 |
1981年 | 58篇 |
1980年 | 67篇 |
1979年 | 32篇 |
1978年 | 55篇 |
1977年 | 57篇 |
1976年 | 57篇 |
1975年 | 37篇 |
Objective
This study assessed the association between the timing of first epinephrine administration (EA) and the neurological outcomes following out-of-hospital cardiac arrests (OHCAs) with both initial shockable and non-shockable rhythms.Methods
This was a post-hoc analysis of a multicenter prospective cohort study (SOS-KANTO 2012), which registered OHCA patients in the Kanto region of Japan from January 2012 to March 2013. We included consecutive adult OHCA patients who received epinephrine. The primary result included 1-month favorable neurological outcomes defined as cerebral performance category (CPC) 1 or 2. Secondary results included 1-month survival and return of spontaneous circulation (ROSC) after arrival at the hospital. Multivariable logistic regression analysis determined the association between delay per minute of the time from call to first EA in both pre- or in-hospital settings and outcomes.Results
Of the 16,452 patients, 9344 were eligible for our analyses. In univariable analysis, the delay in EA was associated with decreased favorable neurological outcomes only when the initial rhythm was a non-shockable rhythm. In multivariable analyses, delay in EA was associated with decreased ROSC (adjusted odds ratio [OR] for one minute delay, 0.97; 95% confidence interval [CI], 0.96–0.98) and 1-month survival (adjusted OR, 0.95; 95% CI, 0.92–0.97) when the initial rhythm was a non-shockable rhythm, whereas during a shockable rhythm, delay in EA was not associated with decreased ROSC and 1-month survival.Conclusions
While assessing the effectiveness of epinephrine for OHCA, we should consider the time-limited effects of epinephrine. Additionally, consideration of early EA based on the pathophysiology is needed. 相似文献Methods: This is a retrospective analysis of discharge records from the National Inpatient Sample database for patients receiving allo-HSCT between 1 January 2009 and 31 December 2013. Allo-HSCT discharges with an aGVHD diagnosis were included in the aGVHD group and those without any graft-versus-host disease (GVHD) diagnosis comprised the non-GVHD group. Mortality, LOS and costs were compared between the two groups, as well as within subgroups, including age (<18 vs. ≥18 years) and survival status (alive vs. deceased) at discharge.
Results: Overall, mortality (16.2% vs. 5.3%; p?<?.01), median hospital LOS (42.0 vs. 26.0 days; p?<?.01) and median total costs ($173,144 vs. $98,982; p?<?.01) were significantly increased in patients with aGVHD versus those without GVHD during hospitalizations for allo-HSCT, irrespective of age group. Patients with aGVHD who were <18 years of age had a lower mortality rate but greater hospital LOS and total costs versus patients aged ≥18 years. Patients who died during allo-HSCT hospitalization had longer LOS and incurred greater costs than those who survived in both the aGVHD and non-GVHD groups.
Conclusion: Occurrence of aGVHD during allo-HSCT admissions resulted in a tripling of the mortality rate and a near doubling of hospital LOS and total costs. In addition, death during allo-HSCT hospitalizations was associated with greater healthcare utilization and costs. Effectively mitigating aGVHD may improve survival and substantially reduce hospital LOS and costs for allo-HSCT. 相似文献